Dr. Reddy`s Laboratories Profit Margin

The latest profit margin for RDY is 9.96% as of June 2026. That compares with 16.99% in the prior-year period — down 41.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Dr. Reddy`s Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, RDY's profit margin moved from 16.99% to 9.96% — a 41.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dr. Reddy`s Laboratories's valuation or profitability profile.

Against Healthcare companies, RDY currently prints 9.96% for profit margin, while the sector average sits near 13.89%. That is roughly 28.3% below the sector mean. Large gaps often invite a closer look at Dr. Reddy`s Laboratories's growth, margins, and balance sheet.

Profit Margin shows how effectively Dr. Reddy`s Laboratories converts resources into returns. At 9.96%, RDY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 16.99% in the prior-year period — down 41.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RDY's profit margin (9.96%), review year-over-year change from 16.99%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.